-

Shareholder Alert: Robbins LLP Announces Acquisition of PAE Incorporated (PAE) by Amentum Government Services LLC May Not Be in Shareholders' Best Interests

SAN DIEGO & FALLS CHURCH, Va.--(BUSINESS WIRE)--Robbins LLP announces that it is investigating the acquisition of PAE Incorporated (NASDAQ: PAE) by Amentum Government Services LLC. Under the terms of the agreement, PAE stockholders will receive $10.15 in cash for each share of PAE common stock owned.

If you own shares of PAE Incorporated, click here.

Is the Proposed Acquisition Best for PAE Incorporated (PAE) and Its Shareholders?

According to the Proxy Statement, PAE's board approved a merger agreement with Amentum in which PAE will become a wholly owned subsidiary of Amentum. The deal is valued at approximately $1.9 billion and is expected to close in the first quarter of 2022. Robbins LLP is concerned that PAE's board of directors engaged in an unfair process and agreed to an unfair amount to be paid to shareholders.

PAE Incorporated (PAE) Shareholders Have Legal Options. If you own shares of PAE Incorporated, contact us to learn more about your legal rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in securities litigation and shareholder rights law. The law firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

Investor Notice: Robbins LLP Informs Investors of the Globant S.A. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025. Globant is a Luxembourg-incorporated international technology company that provides digital consulting and related services. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LL...

Investor Notice: Robbins LLP Informs Investors of the zSpace, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired zSpace, Inc. (NASDAQ: ZSPC) securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company's December 2024 initial public statement ("IPO"). zSpace purports to be a leading provider of augmented reality (AR) and virtual reality (VR) educational technology solutions.For more information, s...
Back to Newsroom